<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-antioxidants-09-01099">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Aladaileh</surname>
    <given-names>S.H.</given-names>
   </name>
   <name>
    <surname>Hussein</surname>
    <given-names>O.E.</given-names>
   </name>
   <name>
    <surname>Abukhalil</surname>
    <given-names>M.H.</given-names>
   </name>
   <name>
    <surname>Saghir</surname>
    <given-names>S.A.M.</given-names>
   </name>
   <name>
    <surname>Bin-Jumah</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Alfwuaires</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Germoush</surname>
    <given-names>M.O.</given-names>
   </name>
   <name>
    <surname>Almaiman</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Mahmoud</surname>
    <given-names>A.M.</given-names>
   </name>
  </person-group>
  <article-title>Formononetin upregulates Nrf2/HO-1 signaling and prevents oxidative stress, inflammation, and kidney injury in methotrexate-induced rats</article-title>
  <source>Antioxidants (Basel Switz.)</source>
  <year>2019</year>
  <volume>8</volume>
  <elocation-id>430</elocation-id>
  <pub-id pub-id-type="doi">10.3390/antiox8100430</pub-id>
 </element-citation>
</ref>
